GNRH1 and cancer: From the findings of the present study, it is highly recommended that fertility preservation services, such as the use of oocyte/embryo cryopreservation, ovarian suppression and GnRH agonists with counselling be provided to patients scheduled to undergo cancer chemotherapy if they still desire to have children folowing treatment.